SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001178913-22-004189
Filing Date
2022-11-29
Accepted
2022-11-29 06:02:05
Documents
15
Period of Report
2022-11-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A zk2228824.htm   iXBRL 8-K/A 35537
2 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 33013
7 image00001.jpg GRAPHIC 4512
  Complete submission text file 0001178913-22-004189.txt   270420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cmmb-20221114.xsd EX-101.SCH 4644
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmmb-20221114_def.xml EX-101.DEF 18765
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmmb-20221114_lab.xml EX-101.LAB 29238
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmmb-20221114_pre.xml EX-101.PRE 21064
9 EXTRACTED XBRL INSTANCE DOCUMENT zk2228824_htm.xml XML 7348
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38807 | Film No.: 221428214
SIC: 2834 Pharmaceutical Preparations